Press release
Global Osteoarthritis Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2020-2026
The global osteoarthritis therapeutics market is estimated to grow at a CAGR of 8.2% during the forecast period. Pipeline products are expected to offer an opportunity for the growth of the market. For instance, in April 2019, Pfizer Inc. and Eli Lilly and Co. declared a Phase III study outcomes assessing tanezumab 2.5 mg and 5 mg. This study was intended to compare the 16-week efficacy of tanezumab and long-term joint safety relative to nonsteroidal anti-inflammatory drugs (NSAIDs) among patients with moderate-to-severe osteoarthritis of the knee or hip. 5 mg treatment arm of the tanezumab met two from the three co-primary endpoints related to efficacy, showing a statistically potential improvement in physical function and pain than NSAIDs at the 16-week analysis.To Request a Sample of our Report on Global Osteoarthritis Therapeutics Market: https://www.omrglobal.com/request-sample/osteoarthritis-therapeutics-market
However, patients who received 2.5 mg tanezumab did not experience a statistically potential improvement in physical function, pain, or overall assessment of patients for their osteoarthritis at 16 weeks than NSAIDs. Under the analysis for safety, there was a potential rate of events regarding joint safety in the tanezumab arms than NSAIDs at 80 weeks. As a monoclonal antibody, Tanezumab is part of an investigational drug class of non-opioid chronic pain medications referred to as nerve growth factor (NGF) inhibitors. These kinds of pipeline products with increased safety and efficacy are expected to offer an opportunity for the launch of new therapies in the future, which in turn, will likely drive the market growth.
Scope of the Global Osteoarthritis Therapeutics Market
Market Coverage
· Market number available for 2019-2026
· Base year- 2019
· Forecast period- 2020-2026
· Segment Covered- By Anatomy and Drug Type
· Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World
· Competitive Landscape- Pfizer Inc., Bayer AG, Zimmer Biomet Holdings, Inc., Sanofi S.A., and GlaxoSmithKline plc
(Get 15% Discount on Buying this Report)
A full Report of Global Osteoarthritis Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/osteoarthritis-therapeutics-market
Recent Strategic Initiatives in the Global Osteoarthritis Therapeutics Market
· In February 2020, GlaxoSmithKline plc declared the US FDA approval of Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID). It is an arthritis pain relief available as an OTC product to temporarily provide relief from arthritis pain in the knee, elbow, hand, ankle, wrist, or foot, in adults (18 years and older). With the approval of the US FDA, Voltaren Arthritis Pain becomes the first and only prescription-strength, NSAID topical gel for arthritis pain available OTC in the US. This approval will offer approximately 30 million Americans suffering from osteoarthritis OTC access to the topical treatment option.
· In January 2019, OrthogenRx, Inc. declared the introduction of TriVisc (sodium hyaluronate) to treat patients with osteoarthritic knee pain who have failed to get sufficient relief from physical therapy or exercise or simple painkillers. TriVisc is a highly purified hyaluronic acid (sodium hyaluronate; HA) solution and supports supplement the viscous properties of the fluid in the knee joint.
Key questions addressed by the report
· What is the market growth rate?
· Which segment/region dominates the market in the base year?
· Which segment/region will project the fastest growth in the market?
· How COVID-19 impacted the market?
Ø Recovery Timeline
Ø Deviation from the pre-COVID forecast
Ø Most affected region/segment
· Who is the leader in the market?
· How players are addressing challenges to sustain growth?
· Where is the investment opportunity?
Global Osteoarthritis Therapeutics Market-Segmentation
By Anatomy
· Knee
· Ankle
· Hip
· Hand
· Spine
By Drug Type
· Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
· Viscosupplementation Agents
· Corticosteroids
· Analgesics
Global Osteoarthritis Therapeutics Market– Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of The World
· Latin America
· Middle East & Africa
Company Profiles
· Abbott Laboratories
· Anika Therapeutics, Inc.
· Assertio Therapeutics, Inc.
· Bioventus LLC
· Eli Lilly and Co.
· Ferring Pharmaceuticals
· Fidia Farmaceutici S.p.A.
· Flexion Therapeutics
· Hanmi Pharmaceutical Co., Ltd.
· Horizon Therapeutics plc
· Iroko Pharmaceuticals, Inc.
· Johnson & Johnson Service, Inc.
· Kitov Pharmaceuticals, Ltd.
· Laboratorio Reig Jofre
· Novartis International AG
· OrthogenRx, Inc
· Virchow Biotech, Pvt. Ltd.
Reasons to Buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/osteoarthritis-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Osteoarthritis Therapeutics Market Growth, Size, Share, Industry Report and Forecast 2020-2026 here
News-ID: 2406648 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…